Refined genetic localization for central core disease
- Adelaide Children's Hospital, North Adelaide (Australia)
- Univ. of Nijmegen (Netherlands)
- Univ. of Wisconsin, Madison (United States)
- Univ. of Toronto, Ontario (Canada)
Central core disease (CCO) is an autosomal dominant myopathy clinically distinct from malignant hyperthermia (MHS). In a large kindred in which the gene for CCO is segregating, two-point linkage analysis gave a maximum lod score, between the central core disease locus (CCO) and the ryanodine receptor locus (RYR1), of 11.8, with no recombination. Mutation within RYR1 is responsible for MHS, and RYR1 is also a candidate locus for CCO. A combination of physical mapping using a radiation-induced human-hamster hybrid panel and of multipoint linkage analysis using the Centre d'Etude du Polymorphisme Humain families established the marker order and sex-average map distances (in centimorgans) on the background map as D19S75-(5.2)-D19S9-(3.4)-D19S191-(2.2)-RYR1-(1.7)-D19S190-(1.6)-D19S47-(2.0)-CYP2B. Recombination was observed between CCO and the markers flanking RYR1. These linkage data are consistent with the hypothesis that CCO and RYR1 are allelic. The most likely position for CCO is near RYR1, with a multipoint lod score of 11.4, in 19q13.1 between D19S191 and D19S190, within the same interval as MHS (RYR1). 24 refs., 3 figs., 2 tabs.
- OSTI ID:
- 6830999
- Journal Information:
- American Journal of Human Genetics; (United States), Vol. 52:2; ISSN 0002-9297
- Country of Publication:
- United States
- Language:
- English
Similar Records
Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1
The gene for autosomal dominant spinocerebellar ataxia (SCAI) maps centromeric to D6S89 and shows no recombination, in nine large kindreds, with a dinucleotide repeat at the AM10 locus